CRISPR and Cas Genes Market Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025

Sep 2018| TMR875A| Transparency

Report Highlights

Global CRISPR and Cas Genes Market: Overview

This report analyzes the current and future scenario of the global CRISPR and Cas genes market. Rise in government spending in research and development of genome editing, increase in incidence of genetic disorders, and usage of CRISPR/Cas9 technology to improve crop production are factors driving the global market. The global CRISPR and Cas genes market has been segmented based on product, application, end-user, and region.

The global CRISPR and Cas genes market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on product, application, end-user, and region. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles along with business overview in order to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global CRISPR and Cas genes market.

Global CRISPR and Cas Genes Market: Key Segments

Based on product, the global CRISPR and Cas genes market has been segmented into vector-based Cas and DNA-free Cas. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

In terms of application, the global CRISPR and Cas genes market has been classified into genome engineering, disease models, functional genomics, knockout/activation, and others. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Based on end-user, the global CRISPR and Cas genes market has been divided into biotechnology & pharmaceutical companies, academic & government research institutes, and contract research organizations. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global CRISPR and Cas Genes Market: Regional Outlook

The global CRISPR and Cas genes market has been segmented into five major regions: North America (U.S. and Canada), Europe (U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, and Rest of Middle East & Africa). The market size and forecast for each of these regions and countries/sub-regions have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in the Report

The report also profiles the major players in the market in terms of various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Key players operating in the global CRISPR and Cas genes market include Synthego, Thermo Fisher Scientific, Inc., GenScript, Addgene, Merck KGaA (Sigma-Aldrich), Integrated DNA Technologies, Inc., Transposagen Biopharmaceuticals, Inc., OriGene Technologies, Inc., New England Biolabs, Dharmacon, Cellecta, Inc., Agilent Technologies, and Applied StemCell Inc. These players are adopting organic and in-organic growth strategies to expand product offerings, strengthen geographical reach, increase customer base, and market share.

The global CRISPR and Cas genes market has been segmented as follows:

Global CRISPR and Cas Genes Market, by Product
Vector-based Cas
DNA-free Cas

Global CRISPR and Cas Genes Market, by Application
Genome Engineering
Disease Models
Functional Genomics
Knockdown/activation
Others

Global CRISPR and Cas Genes Market, by End-user
Biotechnology & Pharmaceutical Companies
Academic & Government Research Institutes
Contract Research Organizations

Global CRISPR and Cas Genes Market, by Region
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia Pacific
India
Japan
China
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of Middle East & Africa

  • Table 1 : Global CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by Product, 2016–2026
  • Table 2 : Global CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by Application, 2016–2026
  • Table 3 : Global CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by End-user, 2016–2026
  • Table 4 : Global CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by Region, 2016–2026
  • Table 5 : North America CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by Country, 2016–2026
  • Table 6 : North America CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
  • Table 7 : North America CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by Application Type, 2016–2026
  • Table 8 : North America CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by End-user, 2016–2026
  • Table 9 : Europe CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 10 : Europe CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
  • Table 11 : Europe CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by Application, 2016–2026
  • Table 12 : Europe CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by End-user, 2016–2026
  • Table 13 : Asia Pacific CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 14 : Asia Pacific CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
  • Table 15 : Asia Pacific CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by Application Type, 2016–2026
  • Table 16 : Asia Pacific CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by End-user, 2016–2026
  • Table 17 : Latin America CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 18 : Latin America CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
  • Table 19 : Latin America CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by Application Type, 2016–2026
  • Table 20 : Latin America CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by End-user, 2016–2026
  • Table 21 : Middle East & Africa CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 22 : Middle East & Africa CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by Product, 2016–2026
  • Table 23 : Middle East & Africa CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by Application, 2016–2026
  • Table 24 : Middle East & Africa CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by End-user, 2016–2026
  • Figure 1 : Global CRISPR and Cas Genes Market Size (US$ Mn) and Distribution, by Region, 2017 and 2026
  • Figure 2 : Market Snapshot
  • Figure 3 : Opportunity Map, 2017
  • Figure 4 : Opportunity Map, 2017
  • Figure 5 : Opportunity Map, 2017
  • Figure 6 : Global CRISPR and Cas Genes Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
  • Figure 7 : Global CRISPR and Cas Genes Market Value Share, by Product, 2017
  • Figure 8 : Global CRISPR and Cas Genes Market Value Share, by Application, 2017
  • Figure 9 : Global CRISPR and Cas Genes Market Value Share, by End-user, 2017
  • Figure 10 : Global CRISPR and Cas Genes Market Value Share, by Region, 2017
  • Figure 11 : Global CRISPR and Cas Genes Market Value Share, by Product, 2017 and 2026
  • Figure 12 : Global CRISPR and Cas Genes Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Vector-based Cas, 2016–2026
  • Figure 13 : Global CRISPR and Cas Genes Market Revenue (US$ Mn) and Y-o-Y Growth (%), by DNA-free Cas, 2016–2026
  • Figure 14 : Global CRISPR and Cas Genes Market Attractiveness Analysis, by Product, 2018–2026
  • Figure 15 : Global CRISPR and Cas Genes Market Value Share, by Application, 2017 and 2026
  • Figure 16 : Global CRISPR and Cas Genes Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Genome Engineering, 2016–2026
  • Figure 17 : Global CRISPR and Cas Genes Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Disease Models, 2016–2026
  • Figure 18 : Global CRISPR and Cas Genes Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Functional Genomics, 2016–2026
  • Figure 19 : Global CRISPR and Cas Genes Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Contract Research Organizations, 2016–2026
  • Figure 20 : Global CRISPR and Cas Genes Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Functional Genomics, 2016–2026
  • Figure 21 : Global CRISPR and Cas Genes Market Attractiveness Analysis, by Application, 2018–2026
  • Figure 22 : Global CRISPR and Cas Genes Market Value Share, by End-user, 2017 and 2026
  • Figure 23 : Global CRISPR and Cas Genes Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Biotechnology & Pharmaceutical Companies, 2016–2026
  • Figure 24 : Global CRISPR and Cas Genes Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Academic & Government Research Institutes, 2016–2026
  • Figure 25 : Global CRISPR and Cas Genes Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Contract Research Organizations, 2016–2026
  • Figure 26 : Global CRISPR and Cas Genes Market Attractiveness Analysis, by End-user, 2018–2026
  • Figure 27 : Global CRISPR and Cas Genes Market Value Share, by Region, 2017 and 2026
  • Figure 28 : Global CRISPR and Cas Genes Market Attractiveness Analysis, by Region, 2018–2026
  • Figure 29 : North America CRISPR and Cas Genes Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
  • Figure 30 : North America CRISPR and Cas Genes Market Value Share, by Country, 2017 and 2026
  • Figure 31 : North America CRISPR and Cas Genes Market Attractiveness, by Country, 2018–2026
  • Figure 32 : North America CRISPR and Cas Genes Market Value Share, by Product Type, 2017 and 2026
  • Figure 33 : North America CRISPR and Cas Genes Market Attractiveness, by Product Type, 2018–2026
  • Figure 34 : North America CRISPR and Cas Genes Market Value Share, by Application Type, 2017 and 2026
  • Figure 35 : North America CRISPR and Cas Genes Market Attractiveness, by Application Type, 2018–2026
  • Figure 36 : North America CRISPR and Cas Genes Market Value Share, by End-user, 2017 and 2026
  • Figure 37 : North America CRISPR and Cas Genes Market Attractiveness, by End-user, 2018–2026
  • Figure 38 : Europe CRISPR and Cas Genes Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
  • Figure 39 : Europe CRISPR and Cas Genes Market Value Share, by Country/Sub-region, 2017 and 2026
  • Figure 40 : Europe CRISPR and Cas Genes Market Attractiveness, by Country/Sub-region, 2018–2026
  • Figure 41 : Europe CRISPR and Cas Genes Market Value Share, by Product Type, 2017 and 2026
  • Figure 42 : Europe CRISPR and Cas Genes Market Attractiveness, by Product Type, 2018–2026
  • Figure 43 : Europe CRISPR and Cas Genes Market Value Share, by Application, 2017 and 2026
  • Figure 44 : Europe CRISPR and Cas Genes Market Attractiveness, by Application, 2018–2026
  • Figure 45 : Europe CRISPR and Cas Genes Market Value Share, by End-user, 2017 and 2026
  • Figure 46 : Europe CRISPR and Cas Genes Market Attractiveness, by End-user, 2018–2026
  • Figure 47 : Asia Pacific CRISPR and Cas Genes Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
  • Figure 48 : Asia Pacific CRISPR and Cas Genes Market Value Share, by Country/Sub-region, 2017 and 2026
  • Figure 49 : Asia Pacific CRISPR and Cas Genes Market Attractiveness, by Country/Sub-region, 2018–2026
  • Figure 50 : Asia Pacific CRISPR and Cas Genes Market Value Share, by Product Type, 2017 and 2026
  • Figure 51 : Asia Pacific CRISPR and Cas Genes Market Attractiveness, by Product Type, 2018–2026
  • Figure 52 : Asia Pacific CRISPR and Cas Genes Market Value Share, by Application Type, 2017 and 2026
  • Figure 53 : Asia Pacific CRISPR and Cas Genes Market Attractiveness, by Application Type, 2018–2026
  • Figure 54 : Asia Pacific CRISPR and Cas Genes Market Value Share, by End-user, 2017 and 2026
  • Figure 55 : Asia Pacific CRISPR and Cas Genes Market Attractiveness, by End-user, 2018–2026
  • Figure 56 : Latin America CRISPR and Cas Genes Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
  • Figure 57 : Latin America CRISPR and Cas Genes Market Value Share, by Country/Sub-region, 2017 and 2026
  • Figure 58 : Latin America CRISPR and Cas Genes Market Attractiveness, by Country/Sub-region, 2018–2026
  • Figure 59 : Latin America CRISPR and Cas Genes Market Value Share, by Product Type, 2017 and 2026
  • Figure 60 : Latin America CRISPR and Cas Genes Market Attractiveness, by Product Type, 2018–2026
  • Figure 61 : Latin America CRISPR and Cas Genes Market Value Share, by Application Type, 2017 and 2026
  • Figure 62 : Latin America CRISPR and Cas Genes Market Attractiveness, by Application Type, 2018–2026
  • Figure 63 : Latin America CRISPR and Cas Genes Market Value Share, by End-user, 2017 and 2026
  • Figure 64 : Latin America CRISPR and Cas Genes Market Attractiveness, by End-user, 2018–2026
  • Figure 65 : Middle East & Africa CRISPR and Cas Genes Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
  • Figure 66 : Middle East & Africa CRISPR and Cas Genes Market Value Share, by Country/Sub-region, 2017 and 2026
  • Figure 67 : Middle East & Africa CRISPR and Cas Genes Market Attractiveness, by Country/Sub-region, 2018–2026
  • Figure 68 : Middle East & Africa CRISPR and Cas Genes Market Value Share, by Product, 2017 and 2026
  • Figure 69 : Middle East & Africa CRISPR and Cas Genes Market Attractiveness, by Product, 2018–2026
  • Figure 70 : Middle East & Africa CRISPR and Cas Genes Market Value Share, by Application, 2017 and 2026
  • Figure 71 : Middle East & Africa CRISPR and Cas Genes Market Attractiveness, by Application, 2018–2026
  • Figure 72 : Middle East & Africa CRISPR and Cas Genes Market Value Share, by End-user, 2017 and 2026
  • Figure 73 : Middle East & Africa CRISPR and Cas Genes Market Attractiveness, by End-user, 2018–2026
  • Figure 74 : Thermo Fisher Scientific Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2017
  • Figure 75 : Thermo Fisher Scientific Inc. Breakdown of Net Sales, by Region, 2017
  • Figure 76 : Thermo Fisher Scientific Inc. Breakdown of Net Sales, by Business Segment, 2017
  • Figure 77 : Thermo Fisher Scientific Inc. R&D Expense (US$ Mn) and Y-o-Y Growth (%), 2013–2017
  • Figure 78 : GenScript Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
  • Figure 79 : GenScript Breakdown of Net Sales, by Region, 2017
  • Figure 80 : GenScript Breakdown of Net Sales, by Business Segment, 2017
  • Figure 81 : GenScript R&D Expense (US$ Mn) and Selling and Distribution (US$ Mn), 2016–2017
  • Figure 82 : Merck KGaA (Sigma Aldrich) Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2017
  • Figure 83 : Merck KGaA (Sigma Aldrich) Breakdown of Net Sales, by Region, 2017
  • Figure 84 : Merck KGaA (Sigma Aldrich) Breakdown of Net Sales, by Business Segment, 2017
  • Figure 85 : Merck KGaA (Sigma Aldrich) Research & Development Market Share (%), by Business Segment, 2017
  • Figure 86 : Agilent Technologies Breakdown of Net Sales, by Region, 2017
  • Figure 87 : Agilent Technologies Breakdown of Net Sales (US$ Mn), by Segment, 2017
  • Figure 88 : Agilent Technologies Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report